Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-endometrial vasopressin injection for bleeding control in placenta accreta during cesarean section
IRCT20191102045310N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in placenta accreta (PAS) comparing Vasopressin injection with Placebo saline injection (2 arms). Primary endpoints: Hemoglobin level before cesarean section, Hemoglobin level after cesarean section and 1 more. Started Mar 2017; status: completed.
02
Drugs
vasopressin
03
Conditions
placenta accreta (PAS)
Beyond the preview
Go deeper on IRCT20191102045310N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191102045310N1.